全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

艾司氯胺酮在改善外科患者围术期焦虑和抑郁中作用的研究进展
Research Progress of Esketamine in Improving Perioperative Depression and Sleep Quality

DOI: 10.12677/acm.2024.1472116, PP. 1073-1078

Keywords: 艾司氯胺酮,围术期,抑郁
Esketamine
, Perioperative Period, Depression

Full-Text   Cite this paper   Add to My Lib

Abstract:

围术期焦虑和抑郁是临床常见且严重的心理问题,尤其是术前已被确诊为焦虑和抑郁的患者。艾司氯胺酮是一种N-甲基-D-天冬氨酸(N-methyl-D-aspartic, NMDA)受体拮抗剂,已被证明可通过直接靶向谷氨酸能神经系统快速改善抑郁症状和自杀意念。本文就近年来有关艾司氯胺酮在改善外科患者围术期焦虑和抑郁中的作用进行综述与总结,为改善患者的临床预后提供参考。
Esketamine is an N-methyl-D-aspartic acid (NMDA) receptor antagonist, which can play the role of anesthesia, analgesia and anti-negative emotions. It is a new clinical anesthetic. During the perioperative period, patients often suffer from depression and poor sleep quality due to nervousness and fear of pain, which is not conducive to the operation and postoperative recovery. Esketamine has a positive effect on anti-depression and improving sleep quality during perioperative period. This paper analyzes and summarizes the clinical application of estaketamine in relieving depression and improving sleep quality in recent years, so as to provide basis for rational use of drugs in clinic.

References

[1]  Fedgchin, M., Trivedi, M., Daly, E.J., Melkote, R., Lane, R., Lim, P., et al. (2019) Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined with a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (Transform-1). International Journal of Neuropsychopharmacology, 22, 616-630.
https://doi.org/10.1093/ijnp/pyz039
[2]  Popova, V., Daly, E.J., Trivedi, M., Cooper, K., Lane, R., Lim, P., et al. (2019) Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined with a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. American Journal of Psychiatry, 176, 428-438.
https://doi.org/10.1176/appi.ajp.2019.19020172
[3]  Daly, E.J., Trivedi, M.H., Janik, A., Li, H., Zhang, Y., Li, X., et al. (2019) Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients with Treatment-Resistant Depression. JAMA Psychiatry, 76, 893-903.
https://doi.org/10.1001/jamapsychiatry.2019.1189
[4]  汪芸荟, 张中军, 郑子豪. 右旋氯胺酮的临床应用研究进展[J]. 今日药学, 2021, 31(10): 797-800.
[5]  Jauhar, S. and Morrison, P. (2019) Esketamine for Treatment Resistant Depression. BMJ, 366, l5572.
https://doi.org/10.1136/bmj.l5572
[6]  Vasiliu, O. (2023) Esketamine for Treatment-Resistant Depression: A Review of Clinical Evidence (Review). Experimental and Therapeutic Medicine, 25, Article No. 111.
https://doi.org/10.3892/etm.2023.11810
[7]  Fanta, S., Kinnunen, M., Backman, J.T. and Kalso, E. (2015) Population Pharmacokinetics of S-Ketamine and Norketamine in Healthy Volunteers after Intravenous and Oral Dosing. European Journal of Clinical Pharmacology, 71, 441-447.
https://doi.org/10.1007/s00228-015-1826-y
[8]  Trimmel, H., Helbok, R., Staudinger, T., Jaksch, W., Messerer, B., Sch?chl, H., et al. (2018) S+-Ketamine. Wiener klinische Wochenschrift, 130, 356-366.
https://doi.org/10.1007/s00508-017-1299-3
[9]  McIntyre, R.S., Rosenblat, J.D., Nemeroff, C.B., Sanacora, G., Murrough, J.W., Berk, M., et al. (2021) Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. American Journal of Psychiatry, 178, 383-399.
https://doi.org/10.1176/appi.ajp.2020.20081251
[10]  Liu, H., Lan, X., Wang, C., Zhang, F., Fu, L., Li, W., et al. (2022) The Efficacy and Safety of Esketamine in the Treatment of Major Depressive Disorder with Suicidal Ideation: Study Protocol for a Randomized Controlled Trial. BMC Psychiatry, 22, Article No. 744.
https://doi.org/10.1186/s12888-022-04388-y
[11]  Zanos, P., Brown, K.A., Georgiou, P., Yuan, P., Zarate, C.A., Thompson, S.M., et al. (2023) NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine. The Journal of Neuroscience, 43, 1038-1050.
https://doi.org/10.1523/jneurosci.1316-22.2022
[12]  Williams, N.R., Heifets, B.D., Blasey, C., Sudheimer, K., Pannu, J., Pankow, H., et al. (2018) Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism. American Journal of Psychiatry, 175, 1205-1215.
https://doi.org/10.1176/appi.ajp.2018.18020138
[13]  Yan, H., Chen, W., Chen, Y., Gao, H., Fan, Y., Feng, M., et al. (2023) Opioid-Free versus Opioid-Based Anesthesia on Postoperative Pain after Thoracoscopic Surgery: The Use of Intravenous and Epidural Esketamine. Anesthesia & Analgesia, 137, 399-408.
https://doi.org/10.1213/ane.0000000000006547
[14]  de Mendon?a Lima, T., Visacri, M.B. and Aguiar, P.M. (2021) Use of Ketamine and Esketamine for Depression: An Overview of Systematic Reviews with Meta-Analyses. European Journal of Clinical Pharmacology, 78, 311-338.
https://doi.org/10.1007/s00228-021-03216-8
[15]  付宝军, 姜静静, 黄玉琼, 等. 超前艾司氯胺酮抑制瑞芬太尼诱发腹腔镜妇科手术患者术后痛觉过敏[J]. 四川医学, 2021, 42(11): 1100-1105.
[16]  丁冰, 寇清晏, 王艳婷, 等. 不同剂量艾司氯胺酮联合罗哌卡因前锯肌平面阻滞对胸腔镜手术病人术后镇痛的影响[J]. 青岛大学学报(医学版), 2024, 60(2): 279-283.
[17]  Pavlidi, P., Megalokonomou, A., Sofron, A., Kokras, N. and Dalla, C. (2021) Pharmacology of Ketamine and Esketamine as Rapid-Acting Antidepressants. Psychiatriki, 32, 55-63.
https://doi.org/10.22365/jpsych.2021.050
[18]  Kasper, S., Cuba?a, W.J., Fagiolini, A., Ramos-Quiroga, J.A., Souery, D. and Young, A.H. (2020) Practical Recommendations for the Management of Treatment-Resistant Depression with Esketamine Nasal Spray Therapy: Basic Science, Evidence-Based Knowledge and Expert Guidance. The World Journal of Biological Psychiatry, 22, 468-482.
https://doi.org/10.1080/15622975.2020.1836399
[19]  Shen, J., Song, C., Lu, X., Wen, Y., Song, S., Yu, J., et al. (2023) The Effect of Low-Dose Esketamine on Pain and Post-Partum Depression After Cesarean Section: A Prospective, Randomized, Double-Blind Clinical Trial. Frontiers in Psychiatry, 13, Article 1038379.
https://doi.org/10.3389/fpsyt.2022.1038379
[20]  Xu, Y., Chen, Q., Li, P. and Song, X. (2023) Safety and Efficacy of Esketamine for Postoperative Analgesia in Pediatric Patients with Hypospadias. Frontiers in Surgery, 10, Article 1131137.
https://doi.org/10.3389/fsurg.2023.1131137
[21]  Xu, L., Wang, C., Deng, C., Dai, S., Zhou, Q., Peng, Y., et al. (2023) Efficacy and Safety of Esketamine for Supplemental Analgesia during Elective Cesarean Delivery. JAMA Network Open, 6, e239321.
https://doi.org/10.1001/jamanetworkopen.2023.9321
[22]  Guo, Y., Ding, X., Wang, S., Wang, F., Zheng, Z. and Zou, L. (2023) Analgesic Effect of Esketamine Combined with Tramadol for Patient-Controlled Intravenous Analgesia after Cesarean Section: A Randomized Controlled Trial. Journal of Pain Research, 16, 3519-3528.
https://doi.org/10.2147/jpr.s427702
[23]  Song, N., Yang, Y., Zheng, Z., Shi, W., Tan, A., Shan, X., et al. (2023) Effect of Esketamine Added to Propofol Sedation on Desaturation and Hypotension in Bidirectional Endoscopy. JAMA Network Open, 6, e2347886.
https://doi.org/10.1001/jamanetworkopen.2023.47886
[24]  Patel, D., Talbot, C., Luo, W., Mulvaney, S. and Byrne, E. (2021) The Use of Esketamine Sedation in the Emergency Department for Manipulation of Paediatric Forearm Fractures: A 5 Year Study. Injury, 52, 1321-1330.
https://doi.org/10.1016/j.injury.2020.12.033
[25]  van de Bunt, J.A., Veldhoen, E.S., Nievelstein, R.A.J., Hulsker, C.C.C., Schouten, A.N.J. and van Herwaarden, M.Y.A. (2017) Effects of Esketamine Sedation Compared to Morphine Analgesia on Hydrostatic Reduction of Intussusception: A Case‐Cohort Comparison Study. Pediatric Anesthesia, 27, 1091-1097.
https://doi.org/10.1111/pan.13226
[26]  Min, M., Du, C., Chen, X. and Xin, W. (2023) Effect of Subanesthetic Dose of Esketamine on Postoperative Rehabilitation in Elderly Patients Undergoing Hip Arthroplasty. Journal of Orthopaedic Surgery and Research, 18, Article No. 268.
https://doi.org/10.1186/s13018-023-03728-2
[27]  Chen, Y., Guo, Y., Wu, H., Tang, Y., Sooranna, S.R., Zhang, L., et al. (2024) Perioperative Adjunctive Esketamine for Postpartum Depression among Women Undergoing Elective Cesarean Delivery. JAMA Network Open, 7, e240953.
https://doi.org/10.1001/jamanetworkopen.2024.0953
[28]  Ling, B., Zhu, Y., Yan, Z., Chen, H., Xu, H., Wang, Q., et al. (2023) Effect of Single Intravenous Injection of Esketamine on Postpartum Depression after Labor Analgesia and Potential Mechanisms: A Randomized, Double-Blinded Controlled Trial. BMC Pharmacology and Toxicology, 24, Article No. 66.
https://doi.org/10.1186/s40360-023-00705-7
[29]  Reif, A., Bitter, I., Buyze, J., Cebulla, K., Frey, R., Fu, D., et al. (2023) Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression. New England Journal of Medicine, 389, 1298-1309.
https://doi.org/10.1056/nejmoa2304145
[30]  D’Andrea, G., Pettorruso, M., Lorenzo, G.D., Mancusi, G., McIntyre, R.S. and Martinotti, G. (2023) Rethinking Ketamine and Esketamine Action: Are They Antidepressants with Mood-Stabilizing Properties? European Neuropsychopharmacology, 70, 49-55.
https://doi.org/10.1016/j.euroneuro.2023.02.010
[31]  Song, B. and Zhu, J. (2021) Mechanisms of the Rapid Effects of Ketamine on Depression and Sleep Disturbances: A Narrative Review. Frontiers in Pharmacology, 12, Article 782457.
https://doi.org/10.3389/fphar.2021.782457
[32]  Wang, M., Zhang, B., Zhou, Y., Wang, C., Zheng, W., Liu, W., et al. (2021) Sleep Improvement Is Associated with the Antidepressant Efficacy of Repeated-Dose Ketamine and Serum BDNF Levels: A Post-Hoc Analysis. Pharmacological Reports, 73, 594-603.
https://doi.org/10.1007/s43440-020-00203-1
[33]  Qiu, D., Wang, X., Yang, J., Chen, S., Yue, C., Hashimoto, K., et al. (2022) Effect of Intraoperative Esketamine Infusion on Postoperative Sleep Disturbance after Gynecological Laparoscopy. JAMA Network Open, 5, e2244514.
https://doi.org/10.1001/jamanetworkopen.2022.44514
[34]  Zhang, Y., Cui, F., Ma, J. and Wang, D. (2023) Mini-Dose Esketamine-Dexmedetomidine Combination to Supplement Analgesia for Patients after Scoliosis Correction Surgery: A Double-Blind Randomised Trial. British Journal of Anaesthesia, 131, 385-396.
https://doi.org/10.1016/j.bja.2023.05.001
[35]  李敏, 冯涛, 余向天, 等. 艾司氯氨酮预处理对乳腺肿瘤手术患者术后睡眠质量及心理状态的影响[J]. 齐齐哈尔医学院学报, 2023, 44(8): 794-797.
[36]  Margraf, A., Ludwig, N., Zarbock, A. and Rossaint, J. (2020) Systemic Inflammatory Response Syndrome after Surgery: Mechanisms and Protection. Anesthesia & Analgesia, 131, 1693-1707.
https://doi.org/10.1213/ane.0000000000005175
[37]  Bonaventura, J., Lam, S., Carlton, M., Boehm, M.A., Gomez, J.L., Solís, O., et al. (2021) Pharmacological and Behavioral Divergence of Ketamine Enantiomers: Implications for Abuse Liability. Molecular Psychiatry, 26, 6704-6722.
https://doi.org/10.1038/s41380-021-01093-2
[38]  Tu, W., Yuan, H., Zhang, S., Lu, F., Yin, L., Chen, C. and Li, J. (2021) Influence of Anesthetic Induction of Propofol Combined with Esketamine on Perioperative Stress and Inflammatory Responses and Postoperative Cognition of Elderly Surgical Patients. American Journal of Translational Research, 13, 1701-1709.
[39]  Yang, H., Zhao, Q., Chen, H., Liu, W., Ding, T., Yang, B., et al. (2021) The Median Effective Concentration of Propofol with Different Doses of Esketamine during Gastrointestinal Endoscopy in Elderly Patients: A Randomized Controlled Trial. British Journal of Clinical Pharmacology, 88, 1279-1287.
https://doi.org/10.1111/bcp.15072
[40]  Agrawal, A. and Goyal, S. (2013) Ketamine in Status Asthmaticus: A Review. Indian Journal of Critical Care Medicine, 17, 154-161.
https://doi.org/10.4103/0972-5229.117048
[41]  Nikayin, S., Murphy, E., Krystal, J.H. and Wilkinson, S.T. (2022) Long-Term Safety of Ketamine and Esketamine in Treatment of Depression. Expert Opinion on Drug Safety, 21, 777-787.
https://doi.org/10.1080/14740338.2022.2066651

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133